Skip to main content

Table 3 Multivariate cox regression of prognostic factors in NPM1 -mutated patients

From: Hierarchical cluster analysis of immunophenotype classify AML patients with NPM1 gene mutation into two groups with distinct prognosis

Factor

Relapse-free survival (RFS) p-value

Odd Ratio

95% CI

Overall survival (OS) p-value

Odd Ratio

95% CI

Elderly(Age > 60 year)

0.015

0.933

0.056-15.647

0.629

NA

NA

Gender (Male vs Female)

0.558

NA

NA

0.871

NA

NA

Immunophenotypic cluster (Group II vs Group I)

<0.001

2.190

0.363-13.219

0.001

10.435

1.217-89.461

White blood cell count

0.371

NA

NA

0.898

NA

NA

Hemoglobin

0.836

NA

NA

0.349

NA

NA

Platelet

0.590

NA

NA

0.237

NA

NA

Lactate dehydrogenase

0.141

NA

NA

0.942

NA

NA

Cytogenetic* (Normokaryotype vs Additional changes)

0.597

NA

NA

0.464

NA

NA

CEBPA mutation (mutant vs wild type)

0.982

NA

NA

0.309

NA

NA

FLT3-ITD (mutant vs wild type)

<0.001

2.243

0.798-6.306

0.387

NA

NA

FLT3-TKD (mutant vs wild type)

0.191

NA

NA

0.135

NA

NA

  1. NA, not applicable, Cytogenetics*: The cytogenetic data includes 91 patients with normal karyotype, 12 patients with additional changes, and 5 patients showed no mitosis.